Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at Guggenheim in a research report issued on Friday, Benzinga reports. Several other equities research analysts have also recently issued reports on the stock. Wolfe Research initiated coverage on shares of Guardant Health in a research report on Wednesday, […]